![Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial](https://www.frontiersin.org/files/Articles/502836/fmed-06-00327-HTML-r1/image_m/fmed-06-00327-g003.jpg)
Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial
![DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION | Journal of the American College DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION | Journal of the American College](https://www.jacc.org/cms/asset/1c703918-2e1e-4c0f-b054-9ad24a8c4fc8/fx1.jpg)
DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION | Journal of the American College
![IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging](https://www.mdpi.com/ijms/ijms-22-13178/article_deploy/html/images/ijms-22-13178-g001.png)
IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
![A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly | NEJM A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2003/nejm_2003.348.issue-7/nejmoa021716/production/images/img_medium/nejmoa021716_t1.jpeg)
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly | NEJM
![The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 - ScienceDirect The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050120301418-fx1.jpg)
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 - ScienceDirect
![Frontiers | Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer's disease Frontiers | Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer's disease](https://www.frontiersin.org/files/Articles/1166973/fnins-17-1166973-HTML/image_m/fnins-17-1166973-g001.jpg)
Frontiers | Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer's disease
![Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care | Journal of the American College of Cardiology Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/162d195b-12e9-425c-bcc0-4f9b1c9edf78/gr1.jpg)
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care | Journal of the American College of Cardiology
![Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research](https://www.ahajournals.org/cms/asset/f1501fa7-0c96-45e0-8151-a5681831aa0b/circresaha.120.317134.fig03.jpg)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
![Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-020-0515-0/MediaObjects/41440_2020_515_Fig1_HTML.png)
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research
![Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial](https://www.frontiersin.org/files/Articles/502836/fmed-06-00327-HTML-r1/image_m/fmed-06-00327-g002.jpg)
Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial
![Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-023-01189-y/MediaObjects/41440_2023_1189_Figa_HTML.png)
Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research
![Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension](https://www.ahajournals.org/cms/asset/0ef8273d-3a19-4f72-9574-cc4ad16fadd2/hypertensionaha.122.19105.fig03.jpg)
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension
![Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/8b39fb3f-22ea-4188-aaee-d29031724f9c/fx1.jpg)
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
![Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials - The Lancet Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/0d6b63ac-bc1f-43d6-a4cd-5e1083d07700/gr1.gif)
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials - The Lancet
![Frontiers | Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19 Frontiers | Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19](https://www.frontiersin.org/files/Articles/1117502/fragi-04-1117502-HTML/image_m/fragi-04-1117502-g001.jpg)
Frontiers | Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19
![Reinventing the ACE inhibitors: some old and new implications of ACE inhibition | Hypertension Research Reinventing the ACE inhibitors: some old and new implications of ACE inhibition | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fhr.2009.184/MediaObjects/41440_2010_Article_BFhr2009184_Fig2_HTML.jpg)
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition | Hypertension Research
![Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients | Cell Discovery Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients | Cell Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41421-020-00221-6/MediaObjects/41421_2020_221_Fig1_HTML.png)